Diamonds and Dogs
1/31/13
Celsion Corp. (CLSN)Celsion is getting crushed today, down 81.17% at $1.51. The chemotherapy drug company saw its shares get demolished after negative news regarding its clinical trial. Celsion announced that its experimental liver cancer therapeutic, ThermoDox, failed to meet its phase 3 endpoint. ThermoDox is being tested for other types of cancer, however for liver cancer the treatment failed its final phase and will not receive US drug approval. CEO, Michael Tardugno said that the company would look for other ways to find strategic value for ThermoDox. Celsion dropped to a new 52-week low today.
Pitney Bowes Inc. (PBI)
Pitney Bowes is trying to climb back up to its highs today, up 20.53% at $14.44. The digital communication company saw its shares go in the green after releasing its earnings report. Pitney Bowes beat slightly on revenues and beat expectations on earnings per share. The company announced revenue of $1.29 billion beating analyst estimates of $1.27 billion. EPS came in at $0.56 again beating Wall Street estimates of $0.49 per share. Pitney Bowes is trading in the middle of its 52-week range of $10.34-$19.65.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.